Khan MA - Search Results

1

Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.

Khan MA, Nasti TH, Saima K, Mallick AI, Firoz A, Wajahul H, Ahmad N, Mohammad O. Khan MA, et al. FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):249-58. doi: 10.1016/j.femsim.2004.03.011. FEMS Immunol Med Microbiol. 2004. PMID: 15196575 Free article.

2

Liposome mediated antigen delivery leads to induction of CD8+ T lymphocyte and antibody responses against the V3 loop region of HIV gp120.

Ahmad N, Khan MA, Owais M. Ahmad N, et al. Among authors: khan ma. Cell Immunol. 2001 May 25;210(1):49-55. doi: 10.1006/cimm.2001.1805. Cell Immunol. 2001. PMID: 11485352

3

Antigen entrapped in the escheriosomes leads to the generation of CD4(+) helper and CD8(+) cytotoxic T cell response.

Syed FM, Khan MA, Nasti TH, Ahmad N, Mohammad O. Syed FM, et al. Among authors: khan ma. Vaccine. 2003 Jun 2;21(19-20):2383-93. doi: 10.1016/s0264-410x(03)00106-3. Vaccine. 2003. PMID: 12744869

4

Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B.

Khan MA, Syed FM, Nasti HT, Saima Dagger K, Haq W, Shehbaz A, Owais M. Khan MA, et al. J Drug Target. 2003 Feb;11(2):93-9. doi: 10.1080/1061186031000119093. J Drug Target. 2003. PMID: 12881195

5

Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model.

Khan MA, Jabeen R, Nasti TH, Mohammad O. Khan MA, et al. J Antimicrob Chemother. 2005 Feb;55(2):223-8. doi: 10.1093/jac/dkh522. Epub 2004 Dec 8. J Antimicrob Chemother. 2005. PMID: 15590713

6

Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice.

Khan MA, Firoz A, Jabeen R, Mohammad O. Khan MA, et al. J Drug Target. 2004;12(7):425-33. doi: 10.1080/10611860412331285215. J Drug Target. 2004. PMID: 15621667

7

Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole.

Khan MA, Jabeen R, Mohammad O. Khan MA, et al. Pharm Res. 2004 Dec;21(12):2207-12. doi: 10.1007/s11095-004-7672-8. Pharm Res. 2004. PMID: 15648251

8

Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.

Khan MA, Ahmad N, Moin S, Mannan A, Wajahul H, Pasha ST, Khan A, Owais M. Khan MA, et al. Among authors: khan a. FEMS Immunol Med Microbiol. 2005 Jun 1;44(3):269-76. doi: 10.1016/j.femsim.2004.12.013. FEMS Immunol Med Microbiol. 2005. PMID: 15907448 Free article.

9

Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.

Khan MA, Nasti TH, Owais M. Khan MA, et al. J Antimicrob Chemother. 2005 Oct;56(4):726-31. doi: 10.1093/jac/dki307. Epub 2005 Aug 26. J Antimicrob Chemother. 2005. PMID: 16126780

10

Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.

Khan MA, Owais M. Khan MA, et al. J Drug Target. 2005 Aug;13(7):423-9. doi: 10.1080/10611860500403222. J Drug Target. 2005. PMID: 16308211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,554 results

Search Page

Filters